Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3-hydroxymethyl-5-aziridinyl-1-methyl-2-(1h-indole-4,7-dione)prop-beta-en-alpha-ol
2. 5-(azridin-1-yl)-3-(hydroxymethyl)-2-((1e)-3-hydroxyprop-1-enyl)-methyl-1h-indole-4,7-dione
3. E 09
4. E-09
5. Eo 9
6. Eo-9
7. Eo9
8. Nsc 382,459
9. Nsc 382459
10. Nsc-382459
11. Qapzola
1. 114560-48-4
2. Eoquin
3. Qapzola
4. Eo-9
5. Nor-701
6. Nsc-382459
7. 5-(aziridin-1-yl)-3-(hydroxymethyl)-2-[(e)-3-hydroxyprop-1-enyl]-1-methylindole-4,7-dione
8. E-85/053
9. Eo9
10. 141304-51-0
11. 5-(azridin-1-yl)-3-(hydroxymethyl)-2-((1e)-3-hydroxyprop-1-enyl)-methyl-1h-indole-4,7-dione
12. Apaziquonum
13. H464zo600o
14. Nsc-382456
15. Neoquin
16. Eo 9 (pharmaceutical)
17. Apaziquone [usan:inn]
18. Apaziquonum [inn-latin]
19. 1h-indole-4,7-dione, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-((1e)-3-hydroxy-1-propenyl)-1-methyl-
20. E09
21. E 09
22. 5-aziridin-1-yl-3-hydroxymethyl-2-((e)-3-hydroxy-propenyl)-1-methyl-1h-indole-4,7-dione
23. Nsc 382459
24. Eoquin (tn)
25. E-09
26. Apaziquone (usan/inn)
27. Nsc 382456
28. Unii-h464zo600o
29. 1h-indole-4,7-dione, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-[(1e)-3-hydroxy-1-propen-1-yl]-1-methyl-
30. Apaziquone [usan]
31. (e)-5-(1-azirinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1h-indole-4,7-dione
32. Apaziquone [mi]
33. Apaziquone [inn]
34. 1h-indole-4,7-dione, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-, (e)-
35. Chembl73822
36. Schembl367964
37. Schembl367965
38. E-85/050
39. Antineoplastic-382459
40. Dtxsid90869587
41. Chebi:177558
42. Zinc1536777
43. N1,n6-diethyl-3-methylhexanediamide
44. Nsc382459
45. Bcp9000309
46. Db12593
47. Cs-0006128
48. D02965
49. Q4779259
50. 1h-indole-4, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-
51. 5-(aziridin-1-yl)-3-(hydroxymethyl)-2-(3-hydroxyprop-1-enyl)-1-methylindole-4,7-dione
52. (e)-5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1h-indole-4,7-dione
53. 5-(1-aziridinyl)-3-(hydroxymethyl)-2-[(1e)-3-hydroxy-1-propen-1-yl]-1-methyl-1h-indole-4,7-dione
54. 5-(1-aziridinyl)-3-(hydroxymethyl)-2-[(1e)-3-hydroxy-1-propen-1-yl]-1-methyl-1h-indole-4,7-dione;
Molecular Weight | 288.30 g/mol |
---|---|
Molecular Formula | C15H16N2O4 |
XLogP3 | -0.5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 4 |
Exact Mass | 288.11100700 g/mol |
Monoisotopic Mass | 288.11100700 g/mol |
Topological Polar Surface Area | 82.5 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 524 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
ABOUT THIS PAGE
45
PharmaCompass offers a list of Apaziquone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Apaziquone manufacturer or Apaziquone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Apaziquone manufacturer or Apaziquone supplier.
PharmaCompass also assists you with knowing the Apaziquone API Price utilized in the formulation of products. Apaziquone API Price is not always fixed or binding as the Apaziquone Price is obtained through a variety of data sources. The Apaziquone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Apaziquone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Apaziquone, including repackagers and relabelers. The FDA regulates Apaziquone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Apaziquone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Apaziquone supplier is an individual or a company that provides Apaziquone active pharmaceutical ingredient (API) or Apaziquone finished formulations upon request. The Apaziquone suppliers may include Apaziquone API manufacturers, exporters, distributors and traders.
click here to find a list of Apaziquone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Apaziquone DMF (Drug Master File) is a document detailing the whole manufacturing process of Apaziquone active pharmaceutical ingredient (API) in detail. Different forms of Apaziquone DMFs exist exist since differing nations have different regulations, such as Apaziquone USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Apaziquone DMF submitted to regulatory agencies in the US is known as a USDMF. Apaziquone USDMF includes data on Apaziquone's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Apaziquone USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Apaziquone suppliers with USDMF on PharmaCompass.
Apaziquone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Apaziquone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Apaziquone GMP manufacturer or Apaziquone GMP API supplier for your needs.
A Apaziquone CoA (Certificate of Analysis) is a formal document that attests to Apaziquone's compliance with Apaziquone specifications and serves as a tool for batch-level quality control.
Apaziquone CoA mostly includes findings from lab analyses of a specific batch. For each Apaziquone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Apaziquone may be tested according to a variety of international standards, such as European Pharmacopoeia (Apaziquone EP), Apaziquone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Apaziquone USP).